Allied Market Research


Adme Toxicology Testing Market

ADME Toxicology Testing Market Size, Share, Competitive Landscape and Trend Analysis Report, by Product Type, by Test and, by End User : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

ADME refers to the absorption, distribution, metabolism, and elimination of the drugs or chemicals in the body. ADME testing plays a vital role in the drug development process. The testing enables pharmaceutical companies to reduce their drug discovery time, cost, and test complications.

The rise in research & development of drugs and increasing demand for various treatments of diseases primarily drive the market growth. Increasing technological advancements and detection of toxicology in the early stages of R&D have favoured pharmaceutical companies by lowering their drug discovery time, cost, and test complication.

Furthermore, increasing healthcare awareness and increasing investments in the healthcare sector by the government and private sector are anticipated to fuel the market growth. However, high costs of tests and stringent government rules & regulations associated with the ADME toxicology testing are the major barriers for the growth of the market. Ongoing R&D in the field of ADME toxicology testing is anticipated to create new opportunities during the forecast period.

The market is segmented on the basis of product type, test, end-user, and region. Based on product type, the market is categorised into instruments, software solutions, assays systems, reagents, and others. Based on test, the ADME toxicology testing market is classified into in-vivo and in-vitro. By end-user, the market is segmented into cosmetics & household products, pharmaceutical industry, animal industry, food industry, and others. By region, it has been analysed across into North America, Europe, Asia-Pacific, and LAMEA.

Key Benefits

  • The study provides an in-depth analysis of the global ADME toxicology testing market, with current trends and future estimations to elucidate investment pockets.
  • Comprehensive analysis of factors that drive and restrict the growth of the market has been provided.
  • The report provides a quantitative analysis to help stakeholders capitalize on prevailing market opportunities¬†in terms of value.
  • Extensive analysis of different segments helps understand various products of the market.
  • Key players have been profiled and their strategies thoroughly analyzed, which predict the competitive outlook of the market.

ADME Toxicology Testing Market Report Highlights

Aspects Details
By Product Type
  • Instruments
  • Software Solutions
  • Assays Systems
  • Reagents
  • Others
By Test
  • In Vivo
  • In Vitro
  • Biochemical Testing
  • Cell Testing
By End User
  • Cosmetics and Household Products
  • Pharmaceutical Industry
  • Animal Industry
  • Food Industry
  • Others
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
Key Market Players

Cyprotex PLC., Accelrys, Inc., Bio Rad Laboratories, Inc., Life Technologies Corporation, Optivia Biotechnology, Inc., Agilent Technologies, Inc., Caliper Life Sciences, Inc., Thermo Fisher Scientific, Inc., Molecular Discovery Ltd., Beckman Coulter, Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

ADME Toxicology Testing Market

Global Opportunity Analysis and Industry Forecast, 2023-2032